Skip to content

Autoimmune SupportAutoimmune Support Medications

This category covers medicines that dampen an overactive immune system, used in autoimmune disease and after organ transplant. They need careful monitoring because they also lower defences against infection.

Medicines in the Autoimmune Support category

Plaquenil

Hydroxychloroquine

200 · 400mg

Formulated to alleviate symptoms of autoimmune conditions, intended to support joint health and relieve inflammation in rheumatoid arthritis and lupus.

From$0.53/ tabletView

Olumiant

Baricitinib

4mg

Developed to support immune system regulation and to address symptoms of autoimmune conditions.

From$119.00/ tabletView

Arava

Leflunomide

10 · 20mg

Indicated to manage rheumatoid arthritis to mitigate joint damage.

From$1.54/ tabletView

Prograf

Tacrolimus

0.5 · 1 · 5mg

Designed to mitigate transplant rejection to support long-term organ health.

From$3.75/ tabletView

Protopic

Tacrolimus

0.03 · 0.1%

Designed to alleviate atopic dermatitis symptoms, formulated to target skin inflammation and to support to manage flare-ups.

From$15.13/ tubeView

Imuran

Azathioprine

25 · 50mg

Developed to target immune system activity, utilized to mitigate inflammation in autoimmune processes and to support transplant rejection prevention.

From$0.85/ tabletView

Neoral

Ciclosporin

25 · 100mg

This medication is intended to support the immune system and is indicated to alleviate risks associated with organ transplant rejection.

From$4.82/ tabletView

Cyclomune

Ciclosporin

0.05 · 0.1%

Developed to support ocular surface inflammation to alleviate dry eye symptoms.

From$40.46/ bottleView

Rapamycin

Sirolimus

1mg

Developed to target the immune response and indicated to support transplant success, this agent is utilized to alleviate the risk of organ rejection.

From$3.96/ tabletView

What’s in this category

Conditions it covers

These medicines are used for rheumatoid arthritis, systemic lupus erythematosus, psoriasis and transplant rejection.

Autoimmune Support in Asia

Autoimmune conditions such as rheumatoid arthritis and lupus are increasingly recognised across Asia, with lupus notably more common in East and Southeast Asian populations. Affordable generic treatments have widened access for patients managing these long-term conditions across the region.